Articles

Intrommune Therapeutics Announces Crowdfunding Financing Campaign to Support Food Allergy Treatment Research

bonne soirée

Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore

Reata Pharmaceuticals, Inc. Announces First Quarter 2018 Financial Results and an Update on Development Programs

Tempus Announces New Initiative to Support Physicians Efforts to Deliver Personalized Medicine

CV Sciences, Inc. to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018

Abeona Therapeutics Announces Upcoming Presentations

Cyclacel Pharmaceuticals to Release First Quarter 2018 Financial Results

MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder and Withdrawal

PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share

Nymox Announces Relocation of Company Headquarters to Switzerland